Resolvin D3 multi-level proresolving actions are host protective during infection

Paul C. Norris1, Hildur Arnardottir1, Julia M. Sanger1, David Fichtner2, Gregory S. Keyes2, Charles N. Serhan1
1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Institutes of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
2Cayman Chemical, Ann Arbor, MI 48108, USA

Tài liệu tham khảo

Serhan, 2014, Pro-resolving lipid mediators are leads for resolution physiology, Nature, 510, 92, 10.1038/nature13479 Tabas, 2013, Anti-inflammatory therapy in chronic disease: challenges and opportunities, Science, 339, 166, 10.1126/science.1230720 Serhan, 2005, Resolution of inflammation: the beginning programs the end, Nat. Immunol., 6, 1191, 10.1038/ni1276 Dennis, 2015, Eicosanoid storm in infection and inflammation, Nat. Rev. Immunol., 15, 511, 10.1038/nri3859 Oh, 2011, Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation, J. Clin. Investig., 121, 569, 10.1172/JCI42545 Chiang, 2012, Infection regulates pro-resolving mediators that lower antibiotic requirements, Nature, 484, 524, 10.1038/nature11042 Winkler, 2013, Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin-triggered 17 R-epimer, Org. Lett., 15, 1424, 10.1021/ol400484u Dalli, 2013, Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents, Chem. Biol., 20, 188, 10.1016/j.chembiol.2012.11.010 Haeggström, 2013, Resolving resolvins, Chem. Biol., 20, 138, 10.1016/j.chembiol.2013.02.003 Bannenberg, 2005, Molecular circuits of resolution: formation and actions of resolvins and protectins, J. Immunol., 174, 4345, 10.4049/jimmunol.174.7.4345 Colas, 2014, Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue, Am. J., 307, C39 Serhan, 2002, Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals, J. Exp. Med., 196, 1025, 10.1084/jem.20020760 Nicolaou, 1989, Stereocontrolled total synthesis of (5Z,8Z,10E,12R,14Z)-12-hydroxy-5,8,10,14-eicosatetraenoic acid [(12R)-HETE], Synthesis, 898, 10.1055/s-1989-27425 Rodriguez, 2001, Total synthesis of 12(R)-HETE, 12(S)-HETE, 2H2-12(R)-HETE and LTB4 from racemic glycidol via hydrolytic kinetic resolution, Tetrahedron, 57, 25, 10.1016/S0040-4020(00)00983-2 Takai, 1986, Simple and selective method for aldehydes (RCHO)→(E)-haloalkenes (RCH:CHX) conversion by means of a haloform-chromous chloride system, J. Am. Chem. Soc., 108, 7408, 10.1021/ja00283a046 Rodriguez, 2003, First total synthesis of the E type I phytoprostanes, Tetrahedron Lett., 44, 7411, 10.1016/j.tetlet.2003.08.042 Duffield, 2006, Resolvin D series and protectin D1 mitigate acute kidney injury, J. Immunol., 177, 5902, 10.4049/jimmunol.177.9.5902 Spite, 2009, Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis, Nature, 461, 1287, 10.1038/nature08541